Salarius Pharmaceuticals
$1.199876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$1.19
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.01 (+0.83%) Today
-$0.03 (-2.46%) As of 1:00 AM UTC after-hours
Why Robinhood?
You can buy or sell SLRX and other stocks, options, and ETFs commission-free!
About SLRX
Salarius Pharmaceuticals, Inc. Common Stock, also called Salarius Pharmaceuticals, is a clinical-stage oncology company. The firm focuses on the development of Salarius’ clinical pipeline, which targets rare, orphan cancers and cancers with a high unmet need. The company was founded in 2014 and is headquartered in Houston, TX. The listed name for SLRX is Salarius Pharmaceuticals, Inc. Common Stock.
CEO
David J. Arthur
Employees
8
Headquarters
Houston, Texas
Founded
2014
Market Cap
23.81M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.97M
High Today
$1.27
Low Today
$1.17
Open Price
$1.22
Volume
1.25M
52 Week High
$3.16
52 Week Low
$0.5552
Collections
SLRX Earnings
-$0.73
-$0.49
-$0.24
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 22, After Hours